This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Harvard College, Zikani Therapeutics, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,071 
1 out of 1 Years Active: 2026
Title: Richard Alm: Innovator in Macrolide Development
Introduction
Richard Alm is an accomplished inventor based in Berlin, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolides for treating infectious diseases. His innovative work has the potential to impact the medical community positively.
Latest Patents
Richard Alm holds a patent for "C10-alkylene substituted 13-membered macrolides and uses thereof." This patent describes 13-membered macrolides, specifically azaketolides, which are designed for the treatment of infectious diseases. The patent outlines methods for preparing these macrolides, pharmaceutical compositions that include them, and methods for treating infections caused by Gram-negative bacteria.
Career Highlights
Throughout his career, Richard Alm has worked with notable institutions, including Harvard College and Zikani Therapeutics, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Richard has collaborated with talented individuals such as Thrimurtulu Neetipalli and Wesley Francis Austin. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Richard Alm's work in the field of macrolides showcases his dedication to addressing infectious diseases through innovative pharmaceutical solutions. His contributions are valuable to the ongoing efforts in medical research and treatment.